<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04742543</url>
  </required_header>
  <id_info>
    <org_study_id>0097-21-TLV</org_study_id>
    <nct_id>NCT04742543</nct_id>
  </id_info>
  <brief_title>Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia</brief_title>
  <official_title>Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of virtual reality glasses as a distraction technique in the&#xD;
      management of acute pain and anxiety during conization of cervix uterus under local&#xD;
      anesthesia&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, open-label, randomized control trial in a tertiary university affiliated&#xD;
      medical center between March 2021 to March 2023. Overall, 100 women referred for conization&#xD;
      of cervix due to cervical dysplasia will be randomly allocated to undergo conization either&#xD;
      with the use of virtual reality glasses (study group) or with standard treatment (control&#xD;
      group). The primary outcome measures will include self-reported pain, anxiety scores, and&#xD;
      vital signs as an indirect measurement of pain and anxiety, including pulse rate (PR) and&#xD;
      respiratory rate (RR). Pain and anxiety outcomes will be measured as numeric rating scores.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>: Parallel Assignment</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessments of pain through pain score parameter</measure>
    <time_frame>20 minutes</time_frame>
    <description>Assessments of pain through pain score parameter of the NRS questionnaire. Pain will be measured using the Numeric Rating Scale (NRS) which is a 11 point scale from 0 to 10 which is a validated score of measuring pain in which 0 is no pain and 10 is the worst imaginable pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessments of pain through physiological parameters</measure>
    <time_frame>20 minutes</time_frame>
    <description>Assessments of pain through physiological parameters of pulse rate. Heart Rate will be measured using heart rate beats per minute</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dysplasia, Cervix</condition>
  <arm_group>
    <arm_group_label>Virtual reality glasses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients referred for conization due to cervical dysplasia under local anesthesia. In this arm , patients will be allocated to undergo the conization procedure with Virtual reality glasses on</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention. standard treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients referred for conization due to cervical dysplasia under local anesthesia. In this arm , patients will be allocated to undergo the conization procedure without virtual reality glasses (no intervention)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SootheVR: AppliedVR, Los Angeles, California a head-mounted display</intervention_name>
    <description>For the study group, virtual reality content will be shown to the participant for the duration of the conization procedure through a head-mounted display, RelieVRTM. The default VR content for the trial will be &quot;swimming with dolphins&quot; or any other content chosen by the participant</description>
    <arm_group_label>Virtual reality glasses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients over 18 years referred for conization of cervix due to cervical dysplasia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients under 18 years&#xD;
&#xD;
          -  pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>all patients are women referred for conization of cervix uterus due to cervical dysplasia</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nadav Michaan, MD</last_name>
    <phone>972527360283</phone>
    <email>nadavmi@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lis Maternity Hospital, Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Nadav Michaan, MD</last_name>
      <email>nadavmi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>eli shprecher, prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>February 5, 2021</last_update_submitted>
  <last_update_submitted_qc>February 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cervical dysplasia; conization; anxiety; pain; virtual reality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

